Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma

Cancer Medicine

Volumn 4, Issue 10, 2015, Pages 1599-1602

  Chaiteerakij, Roongruedee ^a,b   Juran, Brian D ^a   Aboelsoud, Mohammed M ^a   Harmsen, William S ^a   Moser, Catherine D ^a   Giama, Nasra H ^a   Allotey, Loretta K ^a   Mettler, Teresa A ^a   Baichoo, Esha ^a   Zhang, Xiaodan ^a   Therneau, Terry M ^a   Lazaridis, Konstantinos N ^a   Roberts, Lewis R ^a  

^a MAYO CLINIC CANCER CENTER   (United States)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Bile duct cancer; Biliary tract cancer; Gene variant; Genetic susceptibility; Risk factor

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; KLRK1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; PTGS2 PROTEIN, HUMAN;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; COX 2 GENE; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NKG2D GENE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; AGED; BILE DUCT NEOPLASMS; CASE CONTROL STUDY; CHOLANGIOCARCINOMA; GENETICS; MIDDLE AGED; MORTALITY; SCLEROSING CHOLANGITIS;

AGED; BILE DUCT NEOPLASMS; CARCINOGENESIS; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; CYCLOOXYGENASE 2; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84988368684     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.501     Document Type: Article

References (6)

1. Rizvi, S., and G. J. Gores. 2013. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145:1215-1229.
2. Melum, E., T. H. Karlsen, E. Schrumpf, A. Bergquist, E. Thorsby, K. M. Boberg, et al. 2008. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms. Hepatology 47:90-96.
3. Chaiteerakij, R., W. S. Harmsen, C. R. Marrero, M. M. Aboelsoud, A. Ndzengue, J. Kaiya, et al. 2014. A new clinically based staging system for perihilar cholangiocarcinoma. Am. J. Gastroenterol. 109:1881-1890.
4. Bielinski, S. J., H. S. Chai, J. Pathak, J. A. Talwalkar, P. J. Limburg, R. E. Gullerud, et al. 2011. Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels. Mayo Clin. Proc. 86:606-614.
5. Juran, B. D., E. J. Atkinson, E. M. Schlicht, J. J. Larson, D. Ellinghaus, A. Franke, et al. 2011. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis. Liver Int. 31:785-791.
6. Yuan, H. Y., J. J. Chiou, W. H. Tseng, C. H. Liu, C. K. Liu, Y. J. Lin, et al. 2006. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res. 34:W635-W641.